
Albert Health
Developed voice-based health assistant that helps patients to take the right dose at the right time and make life easier for caregivers.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
* | $1.5m | Seed | |
Total Funding | 000k |
USD | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | 141 % | 135 % | 17 % |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Albert Health operates in the healthcare technology sector, focusing on chronic disease management through an AI-driven platform. The company serves patients with chronic conditions such as diabetes, providing them with personalized treatment plans, educational content, and remote healthcare services. Albert Health leverages artificial intelligence and voice technology to enhance user experience and treatment adherence. The business model is primarily subscription-based, offering its services through a mobile application available on both App Store and Google Play. Revenue is generated through user subscriptions and partnerships with healthcare providers. The platform is multilingual, supporting English, Turkish, and Arabic, making it accessible to a diverse user base. Albert Health aims to improve the well-being of chronic disease patients by making treatment more accessible and personalized.
Keywords: AI, chronic disease, diabetes management, voice assistant, healthcare technology, personalized treatment, remote healthcare, multilingual, subscription-based, treatment adherence.